ArrayExpress Gene Expression Atlas home | about the project | faq | feedback | blog | das | api new | help
EXTL3 Homo sapiens
EXTL3 is differentially expressed in 90 experiments [90 up/88 dn]: 16 organism parts: white blood cells [0 up/1 dn], caudate nucleus [0 up/1 dn], ...; 25 disease states: normal [8 up/4 dn], glioblastoma [2 up/0 dn], ...; 21 cell types, 25 cell lines, 17 compound treatments and 19 other conditions.
Synonyms DKFZp686C2342, EXTL1L, EXTL3, KIAA0519, hCG_15474, EXTR1
Orthologs Extl3 (Mus musculus)  botv (Drosophila melanogaster)  rib-2 (Caenorhabditis elegans)  (Compare orthologs)
InterPro Term EXTL2, alpha-1,4-N-acetylhexosaminyltransferase, Exostosin-like
GO Terms glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity, integral to membrane, intrinsic to endoplasmic reticulum membrane, membrane, transferase activity, transferring hexosyl groups
Uniprot O43909  Q53XT3  Q68CZ0 
Search EB-eye ENSG00000012232
REST API
Expression Summary
153 factor values, click each to filter
Factor Value Factor Up/Down
Legend: - number of studies the gene is up/down in
Normal Disease state
4
8
None Compound treatment
3
2
FLAP Compound treatment
2
HNRPA2B Compound treatment
2
MDA-MB-231 Cell line
1
1
MK886 Compound treatment
2
MCF-7 Cell line
2
BT-474 Cell line
1
1
Glioblastoma Disease state
2
Huntington's disease Disease state
2
HeLa Cell line
2
HL-60 Cell line
1
1
SW480 Cell line
1
SW620 Cell line
1
White blood cells Organism part
1
Glucocorticoid resistant Phenotype
1
Pretreatment primary sample Clinical info
1
Lymphatic endothelial cell Cell type
1
Glucocorticoid sensitive Phenotype
1
Caudate nucleus Organism part
1
Kaposi's sarcoma-associated he... Infection
1
Dimethyl sulfoxide Compound treatment
1
Idiopathic dilated cardiomyopa... Disease state
1
Rapamycin Compound treatment
1
Teratozoospermia Disease state
1
Normospermic Disease state
1
Bacterial endotoxin Compound treatment
1
Control Compound treatment
1
Organism_part Material type
1
Cell Material type
1
N/a Test result
1
Breast carcinoma Disease state
1
MCF10A Cell line
1
Tumor Organism part
1
Granulocyte macrophage-colony ... Compound treatment
1
SkinEthic keratinocyte Cell type
1
Epidermal keratinocyte Cell type
1
Not applicable Histology
1
Enzo Labeling Protocol type
1
Pancreas Organism part
1
Ischemic cardiomyopathy Disease state
1
Psoriatic lesional biopsy Clinical info
1
Uninvolved biopsy Clinical info
1
Stimulated polymorphonuclear l... Cell type
1
Unstimulated polymorphonuclear... Cell type
1
Keratinocyte Cell type
1
Stage I Disease staging
1
Methotrexate Compound treatment
1
Native skin Cell type
1
Lipopolysaccharide Compound treatment
1
Johnsen score count 3.2: Serto... Histology
1
Beas2B Cell line
1
Alveolar space neutrophil Cell type
1
Endometrioid carcinoma Disease state
1
Geriatric Developmental stage
1
Pediatric Developmental stage
1
Skeletal muscle Organism part
1
Control RNAi
1
SIM2s RNAi
1
Invasive ductal carcinoma Histology
1
SKBR3 Cell line
1
Baseline uninfected Disease state
1
A549 Cell line
1
Blood Organism part
1
Umbilical cord Organism part
1
Fetus Developmental stage
1
Adult Developmental stage
1
T3aNxMx Disease staging
1
23/43 Genotype
1
BJAB Cell line
1
Uninfected Infection
1
Plasma cell Cell type
1
B lymphocyte Cell type
1
A. fumigatus condia in media Growth condition
1
Actinomycin D Compound treatment
1
Cystic change Histology
1
CD14+ monocyte Cell type
1
Affymetrix Labeling Protocol type
1
Acute lymphocytic leukemia Disease state
1
PC3 Cell line
1
Grade IV Tumor grading
1
CodeLink Labeling Protocol type
1
Johnsen score count 2: Sertoli... Histology
1
HPL1 Cell line
1
AGS Cell line
1
Benign nevi Disease state
1
Epithelial cell Cell type
1
Stromal cell Cell type
1
Differentiated Cell type
1
Naive Cell type
1
Vasectomized Clinical history
1
U87 Cell line
1
U373 Cell line
1
HaCaT Cell line
1
Leydig cell Cell type
1
T47-D Cell line
1
CD34+ Cell type
1
Polycystic ovary syndrome Disease state
1
STK3 overexpression Genotype
1
Trichostatin A Compound treatment
1
Kaposi's sarcoma Disease state
1
Superficial transitional cell ... Disease state
1
Stage II Disease staging
1
0 cm away from the tumor bound... Observation
1
Atrial mycocardium Organism part
1
Ventricular myocardium Organism part
1
Malignant melanoma Disease state
1
Dermatomyositis Disease state
1
HMEC184 Cell line
1
Non-ischemic cardiomyopathy Disease state
1
Head and neck squamous cell ca... Disease state
1
Ciliary ganglion Organism part
1
Primary bone marrow CD34+ stem... Cell type
1
Frontal cortex, superior motor... Organism part
1
T3aN0M0 Disease staging
1
Superficial transitional cell ... Disease state
1
MDA468 Cell line
1
Primary Disease staging
1
Vanadium pentoxide Compound treatment
1
Primary fibroblast Cell type
1
T3bN1M0 Disease staging
1
Training set Population
1
Test set Population
1
Idiopathic infertility Clinical history
1
Homo sapiens Organism
1
Capra hircus Organism
1
CD4+ T cell Cell type
1
5-aza-2'-deoxycytidine + trich... Compound treatment
1
Smooth muscle Organism part
1
S-nitrosoglutathione plus dibu... Compound treatment
1
Lung Organism part
1
Thymus Organism part
1
Chronic lymphocytic leukemia Disease state
1
Ovary Organism part
1
HMT3522S1 Cell line
1
Small cell lung carcinoma Disease state
1
Cyclosporin A, mycophenolate m... Clinical treatment
1
Sirolimus, mycophenolate mofet... Clinical treatment
1
Primary culture 2 Cell line
1
Down syndrome Disease state
1
Pongo pygmaea Organism
1
GLI56 Cell line
1
Superior cervical ganglion Organism part
1
In vitro neutrophil Cell type
1
Lung adenocarcinoma Disease state
1
Media only Growth condition
1
Cryptorchidism Clinical history
1
17/46 Genotype
1
Female Sex
1
Monoclonal gammopathy of undet... Disease state
1
Grade II Tumor grading
1
ITM-E6E7-ST Cell line
1
Hydroxyurea Compound treatment
1
Expression Profiles
E-MEXP-1014: Transcription profiling of two human colon cancer cell lines treated with n-3 PUFA docosahexaenoic acid for 3 different time points
Experimental Factors
Show expression profile  /  experiment details

 
E-AFMX-5: Transcription profiling of human cell lines and tissues (GNF/Novartis)
Experimental Factors
Cell type Organism part Disease state
Show expression profile  /  experiment details

 
E-GEOD-5824: Transcription profiling of human Acute Lymphoblastic Leukemia CEM_C1 cells treated with rapamycin identifies rapamycin as a glucocorticoid resistance reversal agent
Experimental Factors
Phenotype Time Clinical info Dose Compound treatment
Show expression profile  /  experiment details

 
E-GEOD-4646: Transcription profiling of human HUVEC cells infected with Neisseria meningitidis wild type and mutants vs uninfected sampled at 3 time points
Experimental Factors
Time Infection
Show expression profile  /  experiment details

 
E-MEXP-561: Transcription profiling of human lymphatic endothelial cells response to Kaposi-sarcoma herpesvirus
Experimental Factors
Show expression profile  /  experiment details

 
Processing time: 0.128 secs.